Kiran Dallenbach - Profile and Investment Details

Investor Profile

Kiran Dallenbach is a Private Equity Firm, Venture Capital based in Switzerland with a diverse investment portfolio that includes companies such as Noema Pharma, CareX SA, idiag, Activaero, Roche Glycart, Topas Therapeutics, ESBATech, ImevaX, Symetis, Miracor Medical, Anergis, Dolthera GmbH, Precirix, Genkyotex, Hookipa Pharma, Bioheart, Santhera Pharmaceuticals, Tubulis, Evolva, Sequana Medical, VAXIMM, Okairos, Spinal Cord Therapeutics GmbH, AYOXXA, Cardior Pharmaceuticals, ImmunOs Therapeutics, TOLREMO therapeutics, Azafaros, Inotrem, Affimed, 4-Antibody AG, Middle Peak Medical, Humedics, Alentis Therapeutics, SuppreMol, Lumavita, Thommen Medical, Amal Therapeutics, Spinelab, Curetis, Aleva Neurotherapeutics, EyeSense AG, Tricares, Vivendy Therapeutics, Delenex Therapeutics. Over time, Kiran Dallenbach has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Kiran Dallenbach is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Medical Testing, Chemical Engineering, Chemical, Life Science, Biotech, Medical Device, Healthcare, Biotechnology, Neuroscience, Health Diagnostics, Therapeutics, Advanced Materials, Media and Entertainment, Pharmaceuticals, Biopharma may find it worthwhile to explore potential connections with Kiran Dallenbach, as their portfolio suggests a familiarity and interest in this area.

Understanding Kiran Dallenbach’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.